title: Small high-density lipoprotein (HDL) subclasses are increased with decreased activity of HDL-associated phospholipase A₂ in subjects with prediabetes.
abstract: Alterations in high-density lipoprotein (HDL) subclass distribution, as well as in the activities of HDL-associated enzymes, have been associated with increased cardiovascular disease (CVD) risk. HDL subclass distribution and the activities of HDL-associated enzymes remain unknown in prediabetic patients, a condition also associated with increased CVD risk. The aim of the present study was to assess any differences in HDL subclass distribution (using polyacrylamide gel electrophoresis) and in activities of HDL-associated enzymes between prediabetic (impaired fasting glucose, IFG, n = 80) and non-prediabetic subjects (n = 105). Subjects with prediabetes had significantly increased waist circumference, blood pressure and triacylglycerol (TAG) levels compared with subjects with fasting glucose levels <100 mg/dL (all p < 0.05). The proportion of small HDL3 over HDL cholesterol (HDL-C) was significantly increased in prediabetic subjects compared with their controls (p < 0.05). The activity of the anti-atherogenic HDL-associated lipoprotein-associated phospholipase A₂ (HDL-LpPLA₂) was significantly lower in subjects with prediabetes (p < 0.05), whereas the activity of paraoxonase 1 (using both paraoxon and phenyl acetate as substrates) did not significantly differ between subjects with or without prediabetes. In a stepwise linear regression analysis, the proportion of small HDL3 over HDL-C concentration was independently associated with the presence of prediabetes and with total cholesterol and TAG concentration (positively), as well as with HDL-C levels (negatively). We also observed a trend of increased small dense low-density lipoprotein cholesterol levels in prediabetic subjects compared with their controls. Subjects with IFG exhibit increased proportion of small HDL3 particles combined with decreased activity of the anti-atherogenic HDL-LpPLA₂.
authors.affiliation: Department of Internal Medicine, School of Medicine, University of Ioannina, 45110 Ioannina, Greece.
authors.forename: Theodosios D
authors.initials: TD
authors.lastname: Filippatos
authors.forename: Evangelos C
authors.initials: EC
authors.lastname: Rizos
authors.forename: Vasilios
authors.initials: V
authors.lastname: Tsimihodimos
authors.forename: Irene F
authors.initials: IF
authors.lastname: Gazi
authors.forename: Alexandros D
authors.initials: AD
authors.lastname: Tselepis
authors.forename: Moses S
authors.initials: MS
authors.lastname: Elisaf
mesh_terms: D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase / Q000097:blood / Q000378:metabolism*; D000328:Adult; D053304:Apolipoprotein C-II / Q000097:blood / Q000378:metabolism; D053305:Apolipoprotein C-III / Q000097:blood / Q000378:metabolism; D043303:Aryldialkylphosphatase / Q000097:blood / Q000378:metabolism; D001786:Blood Glucose / Q000378:metabolism; D005215:Fasting / Q000097:blood; D005260:Female; D006115:Greece / Q000453:epidemiology; D006801:Humans; D008075:Lipoproteins, HDL / Q000032:analysis / Q000097:blood* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D011236:Prediabetic State / Q000097:blood* / Q000201:enzymology* / Q000453:epidemiology / Q000378:metabolism; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood / Q000378:metabolism; D055105:Waist Circumference
chemical_list: D053304:Apolipoprotein C-II; D053305:Apolipoprotein C-III; D001786:Blood Glucose; D008075:Lipoproteins, HDL; D014280:Triglycerides; D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase; D043303:Aryldialkylphosphatase
references.citation: J Am Coll Cardiol. 2004 Aug 4;44(3):720-32
references.pmid: 15358046
references.citation: Lipids Health Dis. 2012 May 15;11:54
references.pmid: 22584085
references.citation: Diabetes Obes Metab. 2008 Jun;10(6):476-83
references.pmid: 17459096
references.citation: Clin Chem Lab Med. 2006;44(9):1052-9
references.pmid: 16958594
references.citation: Biochim Biophys Acta. 2010 Dec;1801(12):1286-93
references.pmid: 20736082
references.citation: Nat Clin Pract Cardiovasc Med. 2006 Mar;3(3):144-53
references.pmid: 16505860
references.citation: J Intern Med. 2012 Dec;272(6):562-72
references.pmid: 22650159
references.citation: J Cardiovasc Pharmacol Ther. 2009 Mar;14(1):5-13
references.pmid: 19246334
references.citation: Atheroscler Suppl. 2002 Dec;3(4):57-68
references.pmid: 12573364
references.citation: Lipids. 2010 May;45(5):445-50
references.pmid: 20379853
references.citation: Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2185-91
references.pmid: 16123324
references.citation: Curr Med Res Opin. 2008 Jul;24(7):1919-29
references.pmid: 18513463
references.citation: Diabetes Care. 2008 Mar;31(3):596-615
references.pmid: 18308683
references.citation: Expert Opin Pharmacother. 2008 Dec;9(18):3151-8
references.pmid: 19040336
references.citation: Curr Med Res Opin. 2005 Dec;21(12):1997-2006
references.pmid: 16368051
references.citation: Diabetologia. 2005 Mar;48(3):529-38
references.pmid: 15729582
references.citation: J Clin Lipidol. 2008 Aug;2(4):279-84
references.pmid: 21291744
references.citation: Scand J Rheumatol. 2013;42(3):169-75
references.pmid: 23311768
references.citation: Clin Biochem. 2003 Sep;36(6):421-9
references.pmid: 12951168
references.citation: Atherosclerosis. 2007 Aug;193(2):428-37
references.pmid: 16911813
references.citation: Clin Chem Lab Med. 2007;45(2):237-43
references.pmid: 17311515
references.citation: Curr Atheroscler Rep. 2010 Sep;12(5):343-8
references.pmid: 20506005
references.citation: Expert Rev Cardiovasc Ther. 2012 Mar;10(3):353-61
references.pmid: 22390807
references.citation: Metabolism. 2012 Jul;61(7):906-21
references.pmid: 22304839
references.citation: Metabolism. 2006 Jul;55(7):885-91
references.pmid: 16784959
references.citation: Curr Opin Lipidol. 1996 Apr;7(2):69-76
references.pmid: 8743898
references.citation: Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):2181-7
references.pmid: 15388521
references.citation: Arterioscler Thromb Vasc Biol. 2001 Jan;21(1):13-27
references.pmid: 11145929
references.citation: Clin Chim Acta. 2001 Oct;312(1-2):87-95
references.pmid: 11580913
references.citation: Arterioscler Thromb Vasc Biol. 1995 Oct;15(10):1764-73
references.pmid: 7583554
references.citation: Circulation. 2005 Jun 28;111(25):3465-72
references.pmid: 15983261
references.citation: Prog Lipid Res. 2012 Oct;51(4):314-24
references.pmid: 22609245
references.citation: Diabetes. 2011 Oct;60(10):2617-23
references.pmid: 21852676
references.citation: Biochim Biophys Acta. 2009 May;1791(5):327-38
references.pmid: 19272461
references.citation: J Hum Hypertens. 2009 May;23(5):332-8
references.pmid: 19078990
references.citation: Eur J Pharmacol. 2011 Dec 15;672(1-3):9-19
references.pmid: 22020287
references.citation: Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):306-11
references.pmid: 11834533
references.citation: Atheroscler Suppl. 2002 Dec;3(4):49-55
references.pmid: 12573363
references.citation: J Nutr Sci Vitaminol (Tokyo). 2002 Aug;48(4):278-82
references.pmid: 12489818
references.citation: Nutr Metab Cardiovasc Dis. 2008 Sep;18(7):477-82
references.pmid: 17928209
references.citation: Clin Biochem. 2012 May;45(7-8):566-70
references.pmid: 22366373
references.citation: Expert Opin Biol Ther. 2007 Jan;7(1):53-72
references.pmid: 17150019
references.citation: Curr Pharm Des. 2010 May;16(13):1480-93
references.pmid: 20196740
references.citation: Curr Atheroscler Rep. 2004 Sep;6(5):359-65
references.pmid: 15296702
references.citation: Clin Chem. 2005 Dec;51(12):2264-73
references.pmid: 16223884
references.citation: Clin Sci (Lond). 2008 May;114(10):611-24
references.pmid: 18399797
references.citation: Diabetes Care. 2012 Jan;35 Suppl 1:S11-63
references.pmid: 22187469
references.citation: Clin Chem Lab Med. 2008;46(4):490-8
references.pmid: 18605933
references.citation: J Diabetes Complications. 2002 Jan-Feb;16(1):24-8
references.pmid: 11872362
references.citation: Lipids. 2009 Jan;44(1):9-16
references.pmid: 18956219